middle.news
Nexalis Secures $53M Funding Facility to Advance Clinical Trials
9:48am on Thursday 28th of May, 2026 AEST
•
Healthcare
Read Story
Nexalis Secures $53M Funding Facility to Advance Clinical Trials
9:48am on Thursday 28th of May, 2026 AEST
Key Points
New $53 million funding facility replaces previous LFO debt
Facility split into three sub-facilities aligned to clinical programs
Includes 49.35 million options as equity participation for lender
Temporary suspension of study orders pending funding finalisation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nexalis Therapeutics (ASX:NX1)
OPEN ARTICLE